• FDA Approves Drug to Treat Smallpox americanpharmaceuticalreview
    June 09, 2021
    The U.S. FDA approved Tembexa (brincidofovir) to treat smallpox. Although the World Health Organization declared smallpox, a contagious and sometimes fatal infectious disease, eradicated in 1980, there have been longstanding concerns that the virus ...
  • FDA Approves Tembexa (brincidofovir) for the Treatment of Smallpox drugs
    June 07, 2021
    Chimerix today announced that the U.S. Food and Drug Administration (FDA) has granted Tembexa (brincidofovir) tablets and oral suspension approval for the treatment of smallpox. Tembexa is approved for adult and pediatric patients, including neonates.
PharmaSources Customer Service